Form 4: Agenus Inc. Chief Medical Officer Receives Stock Option Grant

Agenus Inc.'s Chief Medical Officer, Steven J. O'Day, was granted 50,000 stock options as a one-time retention award.

Summary

• Steven J. O'Day, Chief Medical Officer of Agenus Inc., received a grant of 50,000 stock options on November 14, 2024.
• These options are a one-time retention award granted to key employees, including executive officers.
• The options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.
• The options have an exercise price of $2.77 and will vest on November 15, 2025.
• The options expire on November 14, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with shareholder value. The sentiment is neutral to positive.

Positives

• The stock option grant serves as a retention incentive for a key executive, the Chief Medical Officer.
• The vesting period of one year may encourage long-term commitment from the executive.

Risks

• The value of the options is dependent on the future performance of Agenus Inc.'s stock price.
• There is a risk that the options may not be valuable if the stock price does not increase above the exercise price.

Future Outlook

The stock options will vest on November 15, 2025, contingent on the executive's continued employment.

Management Comments

• The options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.

Industry Context

Stock option grants are a common practice in the biotechnology industry to attract and retain key talent, particularly executive officers.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in the biotech industry.
• The vesting period of one year is relatively common for executive stock options.
• The exercise price of $2.77 is based on the market price of the stock at the time of the grant.

Stakeholder Impact

• The stock option grant may positively impact shareholders by aligning executive interests with the company's long-term success.
• The grant may positively impact employees by providing a retention incentive.

Key Dates

Keywords

stock options, equity incentive plan, retention award, executive compensation, Agenus Inc., Steven J. O'Day, Chief Medical Officer